Screener
Vor Biopharma VOR Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's shares (diluted)?
- Vor Biopharma (VOR) reported shares (diluted) of 43M in Q1 2026.
- How has Vor Biopharma's shares (diluted) changed year-over-year?
- Vor Biopharma's shares (diluted) increased by 589.2% year-over-year, from 6.2M to 43M.
- What is the long-term trend for Vor Biopharma's shares (diluted)?
- Over 4 years (2021 to 2025), Vor Biopharma's shares (diluted) has grown at a 3.4% compound annual growth rate (CAGR), from 129.5M to 148.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Vor Biopharma's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude